The Efficacy of Rasburicase and Rituximab Combined with FAB Chemotherapy in Children and Adolescents with Newly Diagnosed Stage III/IV, BM plus and CNS plus Mature B-NHL: A Children's Oncology Group Report

被引：0
|
作者：
Goldman, Stanton [1 ]
Galardy, Paul J. [2 ]
Smith, Lynette [3 ]
Perkins, Sherrie L. [4 ,5 ]
Shiramizu, Bruce [6 ]
Gross, Thomas [7 ]
Sanger, Warren G. [8 ]
Harrison, Lauren [9 ]
Cairo, Mitchell S. [9 ]
机构：
[1] Med City Childrens, Dallas, TX USA
[2] Mayo Clin, Rochester, MN USA
[3] Univ Nebraska Med Ctr, COPH Biostat, Omaha, NE USA
[4] Univ Utah, Dept Pathol, Salt Lake City, UT USA
[5] ARUP Labs, Salt Lake City, UT USA
[6] Univ Hawaii, Honolulu, HI 96822 USA
[7] Ohio State Univ, Nationwide Childrens Hosp, Columbus, OH 43210 USA
[8] Univ Nebraska, Med Ctr, Human Genet Lab, Omaha, NE USA
[9] New York Med Coll, Valhalla, NY 10595 USA
来源：
BLOOD | 2011年 / 118卷 / 21期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1161 / 1162
页数：2
相关论文
共 47 条
  • [41] Correction to: FLT3 inhibitor lestaurtinib plus chemotherapy for newly diagnosed KMT2A-rearranged infant acute lymphoblastic leukemia: Children’s Oncology Group trial AALL0631
    Patrick A. Brown
    John A. Kairalla
    Joanne M. Hilden
    ZoAnn E. Dreyer
    Andrew J. Carroll
    Nyla A. Heerema
    Cindy Wang
    Meenakshi Devidas
    Lia Gore
    Wanda L. Salzer
    Naomi J. Winick
    William L. Carroll
    Elizabeth A. Raetz
    Michael J. Borowitz
    Donald Small
    Mignon L. Loh
    Stephen P. Hunger
    Leukemia, 2021, 35 : 1527 - 1527
  • [42] A Study of Rituximab and Ifosfamide, Carboplatin, and Etoposide Chemotherapy in Children with Recurrent/Refractory B-Cell (CD20+) Non-Hodgkin Lymphoma and Mature B-Cell Acute Lymphoblastic Leukemia: A Report From the Children's Oncology Group
    Griffin, Timothy C.
    Weitzman, Sheila
    Weinstein, Howard
    Chang, Myron
    Cairo, Mitchell
    Hutchison, Robert
    Shiramizu, Bruce
    Wiley, Joseph
    Woods, Deborah
    Barnich, Margaret
    Gross, Thomas G.
    PEDIATRIC BLOOD & CANCER, 2009, 52 (02) : 177 - 181
  • [43] Risk based and response adapted radiation therapy for children and adolescents with newly diagnosed advanced stage Hodgkin lymphoma treated with ABVD chemotherapy: a report from the Indian pediatric oncology group study InPOG-HL-15-01
    Jain, Sandeep
    Bakhshi, Sameer
    Seth, Rachna
    Verma, Nishant
    Singh, Manisha
    Mahajan, Amita
    Radhakrishnan, Venkatraman
    Mandal, Piali
    Arora, Ramandeep
    Dinand, Veronique
    Kalra, Manas
    Sharma, Anurag
    Taluja, Ankit
    Thulkar, Sanjay
    Biswas, Ahitagni
    Chandra, Jagdish
    LEUKEMIA & LYMPHOMA, 2022, 63 (05) : 1111 - 1118
  • [44] Rituximab-combined anthracycline-free chemotherapy in newly diagnosed paediatric and adolescent patients with non-high-risk aggressive mature B cell lymphoma: protocol for a single-arm, open-label, multicentre, phase II study (the Japan Children's Cancer Group Multicentre Trial, JPLSG B-NHL-20)
    Sekimizu, Masahiro
    Fukano, Reiji
    Koga, Yuhki
    Mitsui, Tetsuo
    Fujita, Naoto
    Mori, Takeshi
    Hori, Daiki
    Tanaka, Makito
    Ohki, Kentaro
    Iwafuchi, Hideto
    Nakazawa, Atsuko
    Mori, Tetsuya
    Kobayashi, Ryoji
    Hashimoto, Hiroya
    M. Saito, Akiko
    Kamei, Michi
    BMJ OPEN, 2024, 14 (03):
  • [45] FLT3 inhibitor lestaurtinib plus chemotherapy for newly diagnosed KMT2A-rearranged infant acute lymphoblastic leukemia: Children's Oncology Group trial AALL0631 (Feb, 10.1038/s41375-021-01177-6, 2021)
    Brown, Patrick A.
    Kairalla, John A.
    Hilden, Joanne M.
    Dreyer, ZoAnn E.
    Carroll, Andrew J.
    Heerema, Nyla A.
    Wang, Cindy
    Devidas, Meenakshi
    Gore, Lia
    Salzer, Wanda L.
    Winick, Naomi J.
    Carroll, William L.
    Raetz, Elizabeth A.
    Borowitz, Michael J.
    Small, Donald
    Loh, Mignon L.
    Hunger, Stephen P.
    LEUKEMIA, 2021, 35 (05) : 1527 - 1527
  • [46] A Randomized Phase 3 Trial of Blinatumomab Vs Chemotherapy as Post-Reinduction Therapy in High and Intermediate Risk First Relapse of B-Acute Lymphoblastic Leukemia in Children and Adolescents/Young Adults Demonstrates Superior Efficacy and Tolerability of Blinatumomab: A Report From Children's Oncology Group Study AALL1331
    不详
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2020, 18 (02) : 13 - 14
  • [47] A Randomized Phase 3 Trial of Blinatumomab Vs. Chemotherapy As Post-Reinduction Therapy in High and Intermediate Risk (HR/IR) First Relapse of B-Acute Lymphoblastic Leukemia (B-ALL) in Children and Adolescents/Young Adults (AYAs) Demonstrates Superior Efficacy and Tolerability of Blinatumomab: A Report from Children's Oncology Group Study AALL1331
    Brown, Patrick A.
    Ji, Lingyun
    Xu, Xinxin
    Devidas, Meenakshi
    Hogan, Laura
    Borowitz, Michael J.
    Raetz, Elizabeth A.
    Zugmaier, Gerhard
    Sharon, Elad
    Gore, Lia
    Whitlock, James A.
    Pulsipher, Michael A.
    Hunger, Stephen P.
    Loh, Mignon L.
    BLOOD, 2019, 134
12345